Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2007 Negotiating Parental Requests for Medication Elizabeth Kieff, MD Virtual Mentor. 2007;9(6):414-417. doi: 10.1001/virtualmentor.2007.9.6.ccas2-0706. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 1 Melissa D. Colsman, MA and David E. Sandberg, PhD Virtual Mentor. 2005;7(11):727-732. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511. Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 2 David B. Allen, MD Virtual Mentor. 2005;7(11):732-735. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511. Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 3 Wilma C. Rossi, MD, MBe, Virtual Mentor. 2005;7(11):735-738. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Case and Commentary Jun 2007 Negotiating Parental Requests for Medication Elizabeth Kieff, MD Virtual Mentor. 2007;9(6):414-417. doi: 10.1001/virtualmentor.2007.9.6.ccas2-0706.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 1 Melissa D. Colsman, MA and David E. Sandberg, PhD Virtual Mentor. 2005;7(11):727-732. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511.
Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 2 David B. Allen, MD Virtual Mentor. 2005;7(11):732-735. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511.
Case and Commentary Nov 2005 Treating Short Stature with Growth Hormone, Commentary 3 Wilma C. Rossi, MD, MBe, Virtual Mentor. 2005;7(11):735-738. doi: 10.1001/virtualmentor.2005.7.11.ccas2-0511.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.